المؤلفون: Raja Ramachandran, Saurabh Nayak, Manish Rathi, Vivek Kumar, Ranjana W. Minz, Harbir Singh Kohli, Jasmine Sethi, Vinod Kumar

المصدر: Nephrology Dialysis Transplantation. 36:1352-1354

مصطلحات موضوعية: Oncology, Transplantation, medicine.medical_specialty, Primary (chemistry), business.industry, MEDLINE, medicine.disease, Text mining, Membranous nephropathy, Nephrology, Internal medicine, medicine, Rituximab, Dosing, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe0ec97e53a56c29c4e07af70fec337fTest
https://doi.org/10.1093/ndt/gfab037Test

المؤلفون: Jasmine Sethi, Deepesh Lad, Gaurav Prakash, Jasmina Ahluwalia, Ritambhra Nada, Aditya Jandial, Pankaj Malhotra, Alka Khadwal, Nishant Jindal, Arihant Jain

المصدر: Hematology/Oncology and Stem Cell Therapy.

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Thrombotic microangiopathy, business.industry, Incidence (epidemiology), Treatment options, Hematology, General Medicine, urologic and male genital diseases, medicine.disease, Carfilzomib, female genital diseases and pregnancy complications, chemistry.chemical_compound, chemistry, immune system diseases, hemic and lymphatic diseases, Internal medicine, medicine, Proteasome inhibitor, business, neoplasms, Multiple myeloma, medicine.drug

الوصف: Carfilzomib is an irreversible proteasome inhibitor currently approved for the treatment of relapsed multiple myeloma. It has been implicated as a cause of thrombotic microangiopathy (TMA) in several case reports. The incidence, risk factors, and treatment of carfilzomib-related TMA remain unclear. Here we describe the clinical presentation and outcome of a 58-year-old man with biopsy-proven TMA that occurred following treatment with carfilzomib-based therapy. We also reviewed the published literature with regard to the incidence, risk factors, treatment options, and outcome of carfilzomib-related TMA.

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::32137800dd5ccc13c2e97ce648d68497Test
https://doi.org/10.1016/j.hemonc.2020.07.001Test

المؤلفون: Vivek Kumar, Jasmine Sethi, Krishan Lal Gupta, Manish Rathi, Harbir Singh Kohli, Ritambhra Nada, Ashish Sharma, Raja Ramachandran

المصدر: Saudi Journal of Kidney Diseases and Transplantation, Vol 30, Iss 1, Pp 270-272 (2019)
Scopus-Elsevier

مصطلحات موضوعية: Oncology, Graft Rejection, medicine.medical_specialty, biology, business.industry, lcsh:R, lcsh:Medicine, General Medicine, Plasmapheresis, Infections, Combined Modality Therapy, Kidney Transplantation, Bortezomib, Text mining, Internal medicine, medicine, biology.protein, Renal allograft, Humans, Immunologic Factors, Antibody, business, Rituximab

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c23f128b010e6eb501d00ba3985737bTest
https://pubmed.ncbi.nlm.nih.gov/30804297Test

المؤلفون: Manish Rathi, Jasmine Sethi, Ritambra Nada, Vst Pinnamaneni, Pankaj Malhotra, Raja Ramachandran, Harbir Singh Kohli, Vishal Kumar, K.L. Gupta

المصدر: Nephrology. 22:1035-1036

مصطلحات موضوعية: Oncology, Chemotherapy, medicine.medical_specialty, business.industry, Bortezomib, medicine.medical_treatment, General Medicine, 030204 cardiovascular system & hematology, medicine.disease, New onset, Nephropathy, 03 medical and health sciences, 0302 clinical medicine, Nephrology, 030220 oncology & carcinogenesis, Internal medicine, Medicine, Plasmapheresis, business, Multiple myeloma, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::4c07096eba18acbdad498240083e974aTest
https://doi.org/10.1111/nep.12979Test